Skip to main content
SpringerLink
Log in

Primary and Metastatic Hepatic Carcinoid: Is There an Algorithm?

  • Editorials
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934–59.

    Article  PubMed  Google Scholar 

  2. Hassan MM, Yao JC. Increased incidence of carcinoid (C) tumors and improved survival of patients with metastases from 1973–1987 as compared to 1988–1999. Proc Am Soc Clin Oncol 2003; 373.

  3. Surveillance, Epidemiology, and End Results (SEER) data between 1973 and 1999, vol. 2002. Washington, DC: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, 2002.

  4. Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol 2003; 10: 1171–5.

    Article  PubMed  Google Scholar 

  5. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 1998; 187: 88–92; discussion 92–3.

    Article  PubMed  CAS  Google Scholar 

  6. Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 2003; 138: 859–66.

    Article  PubMed  Google Scholar 

  7. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169: 36–42; discussion 42–3.

    Article  PubMed  CAS  Google Scholar 

  8. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197: 29–37.

    Article  PubMed  Google Scholar 

  9. Chamberlain RS, Canes D, Brown KT, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000; 190: 432–45.

    Article  PubMed  CAS  Google Scholar 

  10. McCarter MD, Fong Y. Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol 2001; 8: 38–43.

    Article  PubMed  CAS  Google Scholar 

  11. Vauthey JN, Rousseau DL Jr. Liver imaging. A surgeon’s perspective. Clin Liver Dis 2002; 6: 271–95.

    Article  PubMed  Google Scholar 

  12. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137: 675–80; discussion 80–81.

    Article  PubMed  Google Scholar 

  13. Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness—study in 26 patients. Radiology 2003; 227: 251–60.

    Article  PubMed  Google Scholar 

  14. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59–71.

    Article  PubMed  CAS  Google Scholar 

  15. Cady B, McDermott WV. Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 1985; 201: 204–9.

    Article  PubMed  CAS  Google Scholar 

  16. Moertel CG, Johnson CM, McKusick MA, et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994; 120: 302–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas

    James C. Yao MD

  2. Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas

    Jean-Nicolas Vauthey MD

  3. Department of Surgical Oncology, UTMD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX, 77030

    Jean-Nicolas Vauthey MD

Authors
  1. James C. Yao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Nicolas Vauthey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Nicolas Vauthey MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yao, J.C., Vauthey, JN. Primary and Metastatic Hepatic Carcinoid: Is There an Algorithm?. Ann Surg Oncol 10, 1133–1135 (2003). https://doi.org/10.1245/ASO.2003.10.906

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.10.906

Search

Navigation